Functional genomics and proteomics - The role of nuclear medicine

European Journal of Nuclear Medicine

Volumn 29, Issue 1, 2002, Pages 115-132

  Haberkorn, Uwe ^a   Altmann, Annette ^b   Eisenhut, Michael ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Bioengineering; Nuclear medicine; Pharmacogenomics; Proteomics

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA; TRACER; TRANSCRIPTION FACTOR;

ARTICLE; BIOENGINEERING; CONTROLLED STUDY; DRUG DISTRIBUTION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE SEQUENCE; GENETIC CODE; GENOMICS; HUMAN; HUMAN GENOME; NONHUMAN; PHARMACOGENOMICS; POSITRON EMISSION TOMOGRAPHY; PROTEIN STRUCTURE; PROTEOMICS; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); COMPUTATIONAL BIOLOGY; DNA MUTATIONAL ANALYSIS; DRUG THERAPY; GENES; GENES, REPORTER; GENETIC TECHNIQUES; GENOMICS; HUMANS; MOLECULAR BIOLOGY; PHARMACOGENETICS; PROTEOME; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; TRANSCRIPTION, GENETIC;

EID: 0036169350     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0682-4     Document Type: Article

References (98)

1. The sequence of the human genome
2. Genomic biology
3. The impact of genomics on drug discovery
4. Protein function in the post-genomic era
5. Functional genomics in the post-genome era
6. DNA chips: Promising toys have become powerful tools
7. DNA chip technology ante portas
8. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program
9. A comparison of selected mRNA and protein abundances in human liver
10. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
11. A sampling of the yeast proteome
12. Copper deficiency increases hepatic apolipoprotein A-I synthesis and secretion but does not alter hepatic total cellular apolipoprotein A-I mRNA abundance in rats
13. Rat lactate dehydrogenase A and B subunit concentrations are not regulated by mRNA abundance in liver and heart
14. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics
15. Translation control: Bridging the gap between genomics and proteomics?
16. Posttranscriptional control of gene expression in yeast
17. Isolation of translationally controlled mRNAs by differential screening
18. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray
19. Effects of serum deprivation, insulin and dexamethasone on polysome percentages in C2C12 myoblasts and differentiating myoblasts
20. The fas-induced apoptosis analyzed by high-throughput proteome analysis
21. Proteomics in genomeland
22. Structural genomics: Beyond the human genome project
23. Network of protein-protein interactions in yeast
24. Signalling - 2000 and beyond
25. Analysis of yeast protein kinases using protein chips
26. Assigning protein functions by comparative genome analysis: Protein phylogenetic profiles
27. Detecting protein function and protein-protein interactions from genome sequences
28. Conservation of gene order: A fingerprint of proteins that physically interact
29. A combined algorithm for genome-wide prediction of protein function
30. Structural genomics of microbes: An objective
31. A biological atlas of functional maps
32. Computational methods for the identification of differential and coordinated gene expression
33. A genome-wide transcriptional analysis of the mitotic cell cycle
34. Systematic determination of genetic network architecture
35. A novel genetic system to detect protein-protein interactions
36. The two hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest
37. A biochemical genomics approach for identifying genes by the activity of their products
38. Functional genomics in the mouse: Phenotype-based mutagenesis screens
39. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors
40. 18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections
41. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
42. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography
43. 18F)FHPG
44. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography
45. Gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates
46. Imaging methods in gene therapy of cancer
47. 2 receptor as a reporter gene in living animals
48. 188Re
49. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene
50. In vivo localization of diglycylcysteine-bearing synthetic peptides by nuclear imaging of oxotechnetate transchelation
51. Design of metal-binding green fluorescent protein variants
52. Targeting of green fluorescent protein expression to the cell surface
53. MR imaging and scintigraphy of gene expression through melanin induction
54. Transfer of the human sodium iodide symporter gene enhances iodide uptake in hepatoma cells
55. Quantification of target gene expression by imaging reporter gene expression in living animals
56. Overexpression of a heterologous thymidine kinase delays apoptosis induced by factor deprivation and inhibitors of deoxynucleotide metabolism
57. 2 receptor reporter gene in which ligand binding is uncoupled from signal transduction
58. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
59. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA
60. What if there are only 30,000 human genes?
61. Specificity of antisense oligonucleotides in vivo
62. Antisense inhibition of oncogene expression
63. In vivo antisense imaging
64. Characterization of oligonucleotide transport into living cells
65. Cellular uptake and sub-cellular distribution of phosphorothioate oligonucleotides into cultured cells
66. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model
67. Biodistribution of iodine-125 tyramine transforming growth factor? Antisense oligonucleotide in athymic mice with a human mammary tumor xenograft following intratumoral injection
68. 11C-labeled phosphorothioate oligodeoxynucleotide
69. Scintigraphic imaging of oncogenes with antisense probes: Does it make sense?
70. Antisense imaging of gene expression in the brain in vivo
71. In vivo imaging of oligonucleotides with positron emission tomography
72. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90
73. Computational methods for the identification of genes in vertebrate genomic sequences
74. Visualizing the competitive recognition of TATA-boxes in vertebrate promoters
75. Models for prediction and recognition of eukaryotic promoters
76. Imaging biochemistry inside cells
77. Modifier genes convert "simple" Mendelian disorders to complex traits
78. Pharmacogenetic applications of the Human Genome Project
79. Dissecting human disease in the postgenomic area
80. Recent progress in biomolecular engineering
81. Rapid evolution of protein in vitro by DNA shuffling
82. Directed evolution of proteins by exon shuffling
83. Phage-displayed peptide libraries
84. SH2 and SH3 domains: Potential targets for anti-cancer drug design
85. Combinatorial and computational challenges for biocatalyst design
86. Proteome and proteomics: New technologies, new concepts, and new words
87. HMG-1 as a late mediator of endotoxin lethality in mice
88. Reporter gene imaging: Effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase
89. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy
90. Metabolic design of combination therapy: Use of enhanced fluorodeoxyglucose uptake caused by chemotherapy
91. Fluorodeoxyglucose uptake in vitro: Aspects of method and effects of treatment with gemcitabine
92. F-18-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with 2′,2′-difluoro-2′-deoxycytidine
93. Apoptosis and changes in glucose metabolism after treatment of Morris hepatoma with gemcitabine
94. Multi tracer studies during gene therapy of hepatoma cells with HSV thymidine kinase and ganciclovir
95. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase
96. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase
97. Drug discovery in the next millenium
98. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway